NCT05230602

Brief Summary

To examine whether the addition of tzabar fruit twice a day to a routine daily nutrition regime will: A- Reduce symptoms of fatigue, pain and depression in FM patients B. Have positive influence on quality of life

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
19

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 14, 2021

Completed
2 months until next milestone

First Posted

Study publicly available on registry

February 9, 2022

Completed
4 months until next milestone

Study Start

First participant enrolled

June 1, 2022

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2024

Completed
Last Updated

December 14, 2022

Status Verified

December 1, 2022

Enrollment Period

2 years

First QC Date

December 14, 2021

Last Update Submit

December 12, 2022

Conditions

Outcome Measures

Primary Outcomes (4)

  • consumption of tzabar fruit has a positive influence on the reduction of pain

    Pain will be measured using the Widespread Pain Index (WPI) higher scores indicate greater widespread pain

    Two weeks

  • consumption of tzabar fruit has a positive influence on fatigue

    fatigue will be measured using the Symptom Severity Scale (SSS) (Wolfe et al.,2010). higher scores indicate severe Symptoms including fatigue

    Two weeks

  • consumption of tzabar fruit has a positive influence on fatigue

    fatigue will be measured using the Hebrew version of the quality-of-life questionnaire SF-36 (Levin-Epstein et al., 1998) higher scores indicate beter QOL and less fatigue

    Two weeks

  • consumption of tzabar fruit has a positive influence on depressive symptoms

    Depression will be assessed by Beck Depression Inventory (Beck, 1996). higher scores indicate severe depressive symptoms.Those that will be detected with depression will be refer back to the outpatient clinic for advice and treatment

    Two weeks

Study Arms (2)

Study Group

EXPERIMENTAL

The participants will fill the study scales and will be instructed to eat the tzabar fruit twice a day for two weeks

Dietary Supplement: opuntia (tzabar fruit)

Control Group

NO INTERVENTION

The participants will fill the study scales and will be instructed not to change their diet for two weeks

Interventions

opuntia (tzabar fruit)DIETARY_SUPPLEMENT

consuming of the tzabar fruit twice a day

Study Group

Eligibility Criteria

Age18 Years - 120 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsFibromyalgia (FM) is a chronic and idiopathic syndrome, characterized by a general distributed pain, more prevalent in women
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • women diagnosed with FM
  • Age over 18
  • Fluent in Hebrew

You may not qualify if:

  • sensitivity to tzabar/exotic fruits
  • Suffer from digestive issues, such as irritable bowel syndrome
  • Participating in another interventional study
  • Removal criteria
  • \- Participants who do not complete the study follow-up period.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Soroka Medical Center

Beersheba, Southern District, 151, Israel

Location

MeSH Terms

Conditions

Fibromyalgia

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesRheumatic DiseasesNeuromuscular DiseasesNervous System Diseases

Study Officials

  • Orli Grinstein-Cohen, PhD

    Ben-Gurion University of the Negev/Soroka Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: At the start of the study (T1), the participants will fill the above scales. The participants will then be divided randomly into two equal groups. Group A will be instructed to eat the tzabar fruit twice a day for two weeks, while Group B, the control group, will be instructed not to change their diet. At the end of 14 days (T2) all participants will be re-assessed again. Then Group B will be instructed to eat the tzabar fruit twice a day for 14 days, while Group A, will be instructed to eat their regular diet. During the research period, the participants will be instructed to continue their regular treatment routine, whether this includes taking medication, performing sporting activity, and so on in order to avoid undesirable influences that could bias the research results. The tzabar fruits will be supplied by the research team, in a neutral location. After a month all participants will fill the above scales.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of the Nursing Department Ben Gurion University

Study Record Dates

First Submitted

December 14, 2021

First Posted

February 9, 2022

Study Start

June 1, 2022

Primary Completion

June 1, 2024

Study Completion

June 1, 2024

Last Updated

December 14, 2022

Record last verified: 2022-12

Data Sharing

IPD Sharing
Will not share

Locations